Schizophrenia
Research Study

Researchers at McLean Hospital are conducting a study on schizophrenia for adults who are diagnosed with schizophrenia and no other related psychotic disorders. This study is evaluating an investigational medication that may help address weight gain, thinking and memory challenges, and long-term symptom stability when used alongside standard schizophrenia treatment.

Fast Facts

Adults aged 18-55 with schizophrenia and no other related psychotic disorders

Have a study partner who is willing to participate

Compensation
up to $4,306.50 (participants) and $2,356 (study partners)

Conducted in
Belmont, MA

Additional Information

Right now, there are no approved medications specifically designed to address many of these challenges associated with schizophrenia and antipsychotic treatment. Our researchers are studying whether an investigational medication can safely improve weight management, cognitive functioning (such as thinking and memory), and overall stability in adults with schizophrenia who are already taking medication.

You may be eligible for this study if you meet the following criteria.

Inclusion Criteria:

  • Ages 18-55
  • Diagnosed with schizophrenia (and no other related psychotic disorders)
  • On a stable dose of schizophrenia medication for at least 8 weeks
  • Taking no more than 2 antipsychotic medications
  • Have a study partner who is willing to participate
  • If diagnosed 6 or more years ago, have experienced at least 1 relapse in the last 3 years
  • Live in Massachusetts
  • Willing and able to complete about 25 study visits, some in person and some virtual


Exclusion Criteria:

  • Schizoaffective disorder or other related psychotic disorders
  • Bipolar disorder diagnosis
  • Borderline personality disorder diagnosis
  • Eating disorder diagnosis
  • Currently taking clozapine, lithium, or Cobenfy (xanomeline-trospium chloride)
  • Currently taking a GLP-1 or other weight loss medication

If you are interested in participating, you will first complete a phone screening to determine whether you may qualify.

If eligible, you may:

  1. Attend a screening visit and complete study assessments.
  2. Continue taking your current schizophrenia medication throughout the study.
  3. Receive either the investigational medication or a placebo in addition to your current treatment.
  4. Participate in approximately 25 study visits, including a combination of in-person and virtual appointments.
  5. Complete assessments related to your health, symptoms, weight, thinking and memory, and overall well-being.
  6. Identify a reliable study partner who can participate in certain study activities.
  7. Complete 2 follow-up visits after finishing the study.

Yes. Participants may receive up to $4,306.50 and study partners may receive up to $2,356 for taking part in this research study. The research team can also provide transportation support via Lyft for in-person visits.

There is no cost for you to participate in our research study.